(5Z,9Z,13E)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one

 化学構造式
3879-24-1
CAS番号.
3879-24-1
化学名:
别名:
英語名:
(5Z,9Z,13E)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one
英語别名:
(5Z,9Z,13E)-Teprenone;(5Z,9Z,13E)-Geranylgeranylacetone
CBNumber:
CB13936620
化学式:
C23H38O
分子量:
330.54722
MOL File:
3879-24-1.mol

(5Z,9Z,13E)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one 物理性質

安全性情報

(5Z,9Z,13E)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one 価格

メーカー 製品番号 製品説明 CAS番号 包装 価格 更新時間 購入

(5Z,9Z,13E)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one 化学特性,用途語,生産方法

使用

(5Z,9Z,13E)-Geranylgeranylacetone is the structural analogue of Teprenone (T103500), an anti-ulcerative. Geranylgeranylacetone can induce expression of HSP70, HSPB8, and HSPB1. Induction of HSP70 expression is protective against the development of various diseases, such as inflammatory bowel disease, hypoxic/ischemic brain injury and spinal and bulbar muscular atrophy (cytoprotective and anti-inflammatory effects). Reports indicate that GGA protects against NSAID-induced gastric and intestinal lesions by induction of HSP70 expression. Other studies have shown that GGA induces expression of HSPB8 and HSPB1 and reduces the formation of amyloid oligomers as well as insoluble aggregates in HSPB5 R120G TG mice.

(5Z,9Z,13E)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one 上流と下流の製品情報

原材料

準備製品


(5Z,9Z,13E)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one 生産企業

Global( 5)Suppliers
名前 電話番号 電子メール 国籍 製品カタログ 優位度
China National Standard Pharmaceutical Corporation Limited
+8615391658522
overseasales@yongstandards.com China 11927 58
BOC Sciences 1-631-485-4226; 16314854226
info@bocsci.com United States 14059 65
BOC Sciences 16314854226
info@bocsci.com United States 9926 65
QUALITY CONTROL SOLUTIONS LTD. 13670046396
ORDERS@QCSRM.COM China 18810 58
Cato Research Chemicals Inc. 18933936953
tianwen.zhan@cato-chem.com China 6846 58

  • 3879-24-1
  • (5Z,9Z,13E)-Geranylgeranylacetone
  • (5Z,9Z,13E)-Teprenone
Copyright 2017 © ChemicalBook. All rights reserved